Alright, but I think you're drilling down into needless complexity with the balance of your reply. I don't have any fundamental disagreements with you on that, except that it seems only tangentially tethered to this conversation.
At any rate, as I agreed with you before, the market will determine what the company does and what drugs are produced...
We agree on that. As I said, if this HIV drug works as advertised on those who are within a five day window of being infected, and infection rates even start to reach epidemic proportions in the developed world, you'll see some manufacturer produce mass quantities of this drug for sale.
That is, as long as government regulatory agencies don't suppress or impede its rapid dissemination to the public.
That last sentence could be a big factor in how this all turns out.